Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
주식 순위 #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
주가
$0.14942078
마지막 동기화: 2025-05-15
시가총액
$3.86M
변동 (1일)
0.10%
변동 (1년)
0.00%
국가
DE
거래 Medigene AG (MDG1)

카테고리

Medigene AG (MDG1)의 수익
Jun 2024 기준 수익 TTM: $-16.77M
Medigene AG의 최신 재무 보고서에 따르면 회사의 현재 수익은 $-16.77M입니다. 2022년에 회사는 $-10.06M의 수익을 올렸으며 이는 2021년의 수익 $-11.69M과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Medigene AG의 수익 기록 (2004 ~ 2026)
연말 수익
연도 수익 변화
2026 (TTM) $-16.77M -8.57%
2023 $-18.34M 82.41%
2022 $-10.06M -14.01%
2021 $-11.69M -66.20%
2020 $-34.59M 54.79%
2019 $-22.35M -10.30%
2018 $-24.91M 60.47%
2017 $-15.53M 51.81%
2016 $-10.23M -33.71%
2015 $-15.43M 115.69%
2014 $-7.15M -49.32%
2013 $-14.11M -27.68%
2012 $-19.52M -2.57%
2011 $-20.03M -44.87%
2010 $-36.34M 15.53%
2009 $-31.45M -31.91%
2008 $-46.19M 0.82%
2007 $-45.82M 357.81%
2006 $-10.01M -29.67%
2005 $-14.23M -17.13%
2004 $-17.17M 0.00%
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
$5.27B -31,555.72%
US
$1.95B -11,732.28%
NL
- -
CH
- -
KR
$3.01B -18,023.94%
BE